Mark Warner went on CBS this Sunday to talk about the stuff senators talk about when they want to seem serious: Iran, the DNI, FISA reauthorization, the budget. He told Margaret Brennan this is his last term. He said we need universal healthcare. He said there's no more thankless job than being a Democratic chair of anything. What he did not discuss, presumably because Margaret Brennan did not ask, is that he filed 30 disclosed stock trades in the last 90 days, including purchases in two bank stocks while sitting on the Senate Banking Committee's subcommittees for both Financial Institutions and Securities. The filings are public. The committee assignments are public. The rest is arithmetic.
The Sunday Show, the Farewell Tour, and the Filing Cabinet
Warner's Face the Nation appearance hit the standard notes for a senior Democrat in his final term: worried about executive overreach, worried about Iran, worried about the intelligence community. Bluesky lit up with clips. His line about this being his last term got quoted approvingly by people who find that kind of self-aware institutional fatalism charming.
It's a good line. Warner's a good talker. He's been in the Senate since 2009, he chairs the Intelligence Committee in the minority, and he knows how to fill a Sunday-show segment without saying anything that will haunt him.
Meanwhile, the disclosure filings kept moving.
30 Trades in 90 Days
Per Warner's disclosure record on Blind Trust, the senator filed 30 trades in the last 90 days. Most of them landed on a single date: April 13. On that one day, he sold three ETF positions and bought nine separate securities, including Wells Fargo, Microsoft, Blackstone, Rocket Companies, and Constellation Energy.
The amounts are all in the ,000-5,000 range per the disclosures, so we're not talking about a hedge fund operation. But volume tells its own story. Thirty trades in a quarter from a sitting senator with committee assignments spanning banking, finance, digital assets, and intelligence is a lot of moving parts.
The timing cluster is worth a pause. April 13 was a Sunday, coming off a brutal week for markets as tariff volatility hammered equities. Warner rotated out of broad ETF exposure (selling ETFIWF, ETFIWD, and ETFVUG) and into individual names. Whether that was smart depends on which names you look at.
The Alpha Record: Honest Version
The full scored sample covers 13 trades with enough history to measure 30-day alpha against the S&P 500. The record: 5 positive, 8 negative, mean alpha of negative 3.8 percent. The senator is not printing money here.
The best single trade in the sample was Rocket Companies (ticker: RKT), purchased April 13, up 8.5 percent on a 30-day basis versus the index. Microsoft, also bought April 13, came in at plus 6.3 percent. Fifth Third Bancorp, purchased March 20, returned 7.8 percent over the same window.
The worst: two sales of Amgen (AMGN) on April 6 and April 7, at negative 14.4 and negative 12.9 percent alpha respectively. He sold before the stock moved against that position. Also on the losers list: a sale of an LNG-related position in March that underperformed by 20.1 percent over 30 days. Eight of thirteen scored trades finished in the red. The average outcome is negative.
So if you came here hoping to read about a senator who's been quietly printing alpha from a perch on Finance and Banking: the data doesn't support that. It's below coin-flip. The filings show a member who is active, not a member who is accurate.
The Committee Overlap Trades: These Are the Ones That Matter
The alpha record overall is mediocre. But Blind Trust flags five trades that carry a different kind of weight: positions in sectors that fall directly within Warner's committee jurisdiction.
Warner sits on the Senate Banking Committee and its subcommittees for Financial Institutions and Consumer Protection, Securities, Insurance, and Investment, and Digital Assets. He also sits on the Senate Finance Committee, with subcommittee assignments covering taxation, healthcare, and international trade.
With that in mind:
- Fifth Third Bancorp (FITB), purchased March 20: A regional bank. Warner oversees bank regulation. The trade returned plus 7.8 percent alpha over 30 days.
- Wells Fargo (WFC), purchased April 13: One of the four largest banks in the country. Same committee remit. This one lost 8.7 percent alpha over 30 days. The committee seat didn't help here.
- Microsoft (MSFT), purchased April 13: Warner sits on the Banking subcommittee for Digital Assets, which puts big tech's financial infrastructure adjacent to his oversight work. Plus 6.3 percent alpha over 30 days.
- Apple (AAPL), purchased March 20: Same Technology/Digital Assets overlap. Plus 2.8 percent.
- Amgen (AMGN), sold April 6 and April 7: Warner's Finance Committee subcommittee covers healthcare. Amgen is a major biotech with significant Medicare and drug-pricing exposure. He sold on two consecutive days. The stock then went up. Negative 12.9 and negative 14.4 percent alpha on those two trades.
The committee-overlap trades do not show a senator who's cashing in on special insight. The two bank trades split: one winner, one loser. The Amgen sales were timed badly in hindsight. What the overlap trades show is a senator who is actively trading individual equities in sectors he directly oversees, with results that range from fine to bad.
Members are required to disclose within 45 days. They are not required to divest, recuse, abstain, or even acknowledge the tension. That's the rule. Yes, really.
The Votes Running Alongside
Warner's recent floor votes include a few worth noting in context. On June 3, he voted yes on a motion to proceed on a Congressional Review Act resolution to block an EPA rule repealing emission standards for coal- and oil-fired power plants. The motion failed. He was on the losing side. He also holds a position in Constellation Energy (CORPCEG), a nuclear and power generation company purchased April 13, though power-sector regulation doesn't fall squarely within his committee jurisdiction, so that's a floor vote, not a committee angle.
On May 19 and May 13, Warner voted yes on motions to discharge a war powers resolution directing the removal of U.S. Forces from hostilities with Iran. This tracks with his Face the Nation appearance, where he discussed the Iran situation at length in his capacity as vice chair of the Intelligence Committee. The May 19 motion passed; the May 13 one failed.
None of these votes produce a clean trade-vote overlap in the flagged data. There are no vote-trade timing collisions in the structured brief for this period. The votes and the trades are running in parallel, not intersecting on dates in a way that raises a direct timing question.
The Farewell-Tour Math
Warner said this is his last term. He said he works in the only place where nothing gets done. He said, per the social clips circulating on Bluesky, that there's no more thankless job than being a Democratic chair. Taken at face value, it's the kind of self-deprecating candor that plays well in June 2026.
What the filings show is a man who, whatever his plans after the Senate, is not disengaging from markets. Thirty trades in 90 days is an active posture. Nine trades on a single Sunday in April, rotating out of ETFs and into individual names including two banks he oversees, is not the behavior of someone winding down their portfolio for an orderly exit from public life.
The overall alpha record is negative 3.8 percent mean across 13 scored trades, 5 wins and 8 losses. The committee-overlap trades include a bank winner, a bank loser, a pair of healthcare losers, and two tech winners. There's no pattern here that reads as systematically exploited information. There's a pattern that reads as an active trader who sits on powerful committees and produces average-to-below-average results.
Whether that's reassuring or not is a judgment call the disclosure system deliberately leaves to you.
The receipts are public. Make of them what you make of them.